Biologics and Biosimilars Market Research: Global Status & Forecast by Geography, Type & Application (2017-2027)
According to 99Strategy, the Global Biologics and Biosimilars Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Biologics and Biosimilars market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
- Asia Pacific
- North America
- Europe
- South America
- Middle East & Africa
- NatureWorks
- Braskem
- BASF
- Arkema
- DuPont
- Novamont
- Corbion
- Metabolix
- PSM
- PolyOne
- Biome Bioplastics
- Biomer
- FKuR
- Trellis Bioplastics
- Kingfa
- Cardia Bioplastics
- Grabio
- MHG
- Myriant
- Mitsubishi
- Zhejiang Hisun Biomaterials
- Bio-PET
- PHA
- Bio-PE
- Starch Blends
- PLA
- Others
- Packing Industry
- Automotive Industry
- Bottles manufacturing
- Others
- Overview of the Biologics and Biosimilars market including production, consumption, status & forecast and market growth
- 2017-2021 historical data and 2022-2027 market forecast
- Geographical analysis including major countries
- Overview the product type market including development
- Overview the end-user market including development
1 INDUSTRIAL CHAIN OVERVIEW
1.1 Biologics and Biosimilars Industry
1.1.1 Overview
Figure Biologics and Biosimilars Picture List
1.1.2 Characteristics of Biologics and Biosimilars
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Bio-PET
1.3.2 PHA
1.3.3 Bio-PE
1.3.4 Starch Blends
1.3.5 PLA
1.3.6 Others
1.4 End-Use List
1.4.1 Demand in Packing Industry
1.4.2 Demand in Automotive Industry
1.4.3 Demand in Bottles manufacturing
1.4.4 Demand in Others
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2017-2027
Figure Global Market Size and Forecast with Growth Rate, 2017-2027
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027
Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027
Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027
Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027
2 GLOBAL PRODUCTION & CONSUMPTION BY GEOGRAPHY
2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD
2.1.2 Global Consumption
Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.2 North America
Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.3 South America
Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.4 Europe
Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.2 North America
Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD
Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.3 South America
Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD
Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.4 Europe
Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD
3 MAJOR MANUFACTURERS INTRODUCTION
3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Production Amount List in 2021
3.2 Manufacturers List
3.2.1 NatureWorks Overview
Table NatureWorks Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of NatureWorks (Production Amount (Million USD), Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Braskem Overview
Table Braskem Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Braskem (Production Amount (Million USD), Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 BASF Overview
Table BASF Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of BASF (Production Amount (Million USD), Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Arkema Overview
Table Arkema Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Arkema (Production Amount (Million USD), Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 DuPont Overview
Table DuPont Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of DuPont (Production Amount (Million USD), Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Novamont Overview
Table Novamont Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Novamont (Production Amount (Million USD), Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Corbion Overview
Table Corbion Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Corbion (Production Amount (Million USD), Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Metabolix Overview
Table Metabolix Overview List
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Metabolix (Production Amount (Million USD), Cost, Gross Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 PSM Overview
Table PSM Overview List
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of PSM (Production Amount (Million USD), Cost, Gross Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 PolyOne Overview
Table PolyOne Overview List
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of PolyOne (Production Amount (Million USD), Cost, Gross Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Biome Bioplastics Overview
Table Biome Bioplastics Overview List
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Biome Bioplastics (Production Amount (Million USD), Cost, Gross Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Biomer Overview
Table Biomer Overview List
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Biomer (Production Amount (Million USD), Cost, Gross Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 FKuR Overview
Table FKuR Overview List
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of FKuR (Production Amount (Million USD), Cost, Gross Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Trellis Bioplastics Overview
Table Trellis Bioplastics Overview List
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Trellis Bioplastics (Production Amount (Million USD), Cost, Gross Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 Kingfa Overview
Table Kingfa Overview List
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Kingfa (Production Amount (Million USD), Cost, Gross Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Cardia Bioplastics Overview
Table Cardia Bioplastics Overview List
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Cardia Bioplastics (Production Amount (Million USD), Cost, Gross Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
3.2.17 Grabio Overview
Table Grabio Overview List
3.2.17.1 Product Specifications
3.2.17.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Grabio (Production Amount (Million USD), Cost, Gross Margin)
3.2.17.3 Recent Developments
3.2.17.4 Future Strategic Planning
3.2.18 MHG Overview
Table MHG Overview List
3.2.18.1 Product Specifications
3.2.18.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of MHG (Production Amount (Million USD), Cost, Gross Margin)
3.2.18.3 Recent Developments
3.2.18.4 Future Strategic Planning
3.2.19 Myriant Overview
Table Myriant Overview List
3.2.19.1 Product Specifications
3.2.19.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Myriant (Production Amount (Million USD), Cost, Gross Margin)
3.2.19.3 Recent Developments
3.2.19.4 Future Strategic Planning
3.2.20 Mitsubishi Overview
Table Mitsubishi Overview List
3.2.20.1 Product Specifications
3.2.20.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Mitsubishi (Production Amount (Million USD), Cost, Gross Margin)
3.2.20.3 Recent Developments
3.2.20.4 Future Strategic Planning
3.2.21 Zhejiang Hisun Biomaterials Overview
Table Zhejiang Hisun Biomaterials Overview List
3.2.21.1 Product Specifications
3.2.21.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Zhejiang Hisun Biomaterials (Production Amount (Million USD), Cost, Gross Margin)
3.2.21.3 Recent Developments
3.2.21.4 Future Strategic Planning
4 MARKET COMPETITION PATTERN
4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2017-2021, in Million USD
Figure Global Competition Sketch Overview
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD
Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD
Figure Global Production Amount Share by Manufacturers in 2021, in Million USD
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 PRODUCT TYPE SEGMENT
5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD
5.2 Segment Subdivision by Product Type
5.2.1 Market in Bio-PET
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Bio-PET, 2017-2021, in USD Million
5.2.1.2 Situation & Development
5.2.2 Market in PHA
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in PHA, 2017-2021, in USD Million
5.2.2.2 Situation & Development
5.2.3 Market in Bio-PE
5.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Bio-PE, 2017-2021, in USD Million
5.2.3.2 Situation & Development
5.2.4 Market in Starch Blends
5.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Starch Blends, 2017-2021, in USD Million
5.2.4.2 Situation & Development
5.2.5 Market in PLA
5.2.5.1 Market Size
Figure Global Market Amount and Growth Rate in PLA, 2017-2021, in USD Million
5.2.5.2 Situation & Development
5.2.6 Market in Others
5.2.6.1 Market Size
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million
5.2.6.2 Situation & Development
6 END-USE SEGMENT
6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD
6.2 Segment Subdivision
6.2.1 Market in Packing Industry
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Packing Industry, 2017-2021, in USD Million
6.2.1.2 Situation & Development
6.2.2 Market in Automotive Industry
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Automotive Industry, 2017-2021, in USD Million
6.2.2.2 Situation & Development
6.2.3 Market in Bottles manufacturing
6.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Bottles manufacturing, 2017-2021, in USD Million
6.2.3.2 Situation & Development
6.2.4 Market in Others
6.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million
6.2.4.2 Situation & Development
7 MARKET FORECAST & TREND
7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2022-2027, in Million USD
7.2 Consumption Forecast
7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2022-2027, in Million USD
7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2022-2027, in Million USD
7.3 Investment Trend
7.4 Consumption Trend
8 PRICE & CHANNEL
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio
8.2 Channel Segment
9 MARKET DRIVERS & INVESTMENT ENVIRONMENT
9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Biologics and Biosimilars Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 RESEARCH CONCLUSION
1.1 Biologics and Biosimilars Industry
1.1.1 Overview
Figure Biologics and Biosimilars Picture List
1.1.2 Characteristics of Biologics and Biosimilars
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Bio-PET
1.3.2 PHA
1.3.3 Bio-PE
1.3.4 Starch Blends
1.3.5 PLA
1.3.6 Others
1.4 End-Use List
1.4.1 Demand in Packing Industry
1.4.2 Demand in Automotive Industry
1.4.3 Demand in Bottles manufacturing
1.4.4 Demand in Others
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2017-2027
Figure Global Market Size and Forecast with Growth Rate, 2017-2027
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027
Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027
Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027
Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027
2 GLOBAL PRODUCTION & CONSUMPTION BY GEOGRAPHY
2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD
2.1.2 Global Consumption
Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.2 North America
Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.3 South America
Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.4 Europe
Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.2 North America
Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD
Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.3 South America
Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD
Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.4 Europe
Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD
3 MAJOR MANUFACTURERS INTRODUCTION
3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Production Amount List in 2021
3.2 Manufacturers List
3.2.1 NatureWorks Overview
Table NatureWorks Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of NatureWorks (Production Amount (Million USD), Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Braskem Overview
Table Braskem Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Braskem (Production Amount (Million USD), Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 BASF Overview
Table BASF Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of BASF (Production Amount (Million USD), Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Arkema Overview
Table Arkema Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Arkema (Production Amount (Million USD), Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 DuPont Overview
Table DuPont Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of DuPont (Production Amount (Million USD), Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Novamont Overview
Table Novamont Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Novamont (Production Amount (Million USD), Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Corbion Overview
Table Corbion Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Corbion (Production Amount (Million USD), Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Metabolix Overview
Table Metabolix Overview List
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Metabolix (Production Amount (Million USD), Cost, Gross Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 PSM Overview
Table PSM Overview List
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of PSM (Production Amount (Million USD), Cost, Gross Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 PolyOne Overview
Table PolyOne Overview List
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of PolyOne (Production Amount (Million USD), Cost, Gross Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Biome Bioplastics Overview
Table Biome Bioplastics Overview List
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Biome Bioplastics (Production Amount (Million USD), Cost, Gross Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Biomer Overview
Table Biomer Overview List
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Biomer (Production Amount (Million USD), Cost, Gross Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 FKuR Overview
Table FKuR Overview List
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of FKuR (Production Amount (Million USD), Cost, Gross Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Trellis Bioplastics Overview
Table Trellis Bioplastics Overview List
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Trellis Bioplastics (Production Amount (Million USD), Cost, Gross Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 Kingfa Overview
Table Kingfa Overview List
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Kingfa (Production Amount (Million USD), Cost, Gross Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Cardia Bioplastics Overview
Table Cardia Bioplastics Overview List
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Cardia Bioplastics (Production Amount (Million USD), Cost, Gross Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
3.2.17 Grabio Overview
Table Grabio Overview List
3.2.17.1 Product Specifications
3.2.17.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Grabio (Production Amount (Million USD), Cost, Gross Margin)
3.2.17.3 Recent Developments
3.2.17.4 Future Strategic Planning
3.2.18 MHG Overview
Table MHG Overview List
3.2.18.1 Product Specifications
3.2.18.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of MHG (Production Amount (Million USD), Cost, Gross Margin)
3.2.18.3 Recent Developments
3.2.18.4 Future Strategic Planning
3.2.19 Myriant Overview
Table Myriant Overview List
3.2.19.1 Product Specifications
3.2.19.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Myriant (Production Amount (Million USD), Cost, Gross Margin)
3.2.19.3 Recent Developments
3.2.19.4 Future Strategic Planning
3.2.20 Mitsubishi Overview
Table Mitsubishi Overview List
3.2.20.1 Product Specifications
3.2.20.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Mitsubishi (Production Amount (Million USD), Cost, Gross Margin)
3.2.20.3 Recent Developments
3.2.20.4 Future Strategic Planning
3.2.21 Zhejiang Hisun Biomaterials Overview
Table Zhejiang Hisun Biomaterials Overview List
3.2.21.1 Product Specifications
3.2.21.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Biologics and Biosimilars Business Operation of Zhejiang Hisun Biomaterials (Production Amount (Million USD), Cost, Gross Margin)
3.2.21.3 Recent Developments
3.2.21.4 Future Strategic Planning
4 MARKET COMPETITION PATTERN
4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2017-2021, in Million USD
Figure Global Competition Sketch Overview
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD
Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD
Figure Global Production Amount Share by Manufacturers in 2021, in Million USD
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 PRODUCT TYPE SEGMENT
5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD
5.2 Segment Subdivision by Product Type
5.2.1 Market in Bio-PET
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Bio-PET, 2017-2021, in USD Million
5.2.1.2 Situation & Development
5.2.2 Market in PHA
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in PHA, 2017-2021, in USD Million
5.2.2.2 Situation & Development
5.2.3 Market in Bio-PE
5.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Bio-PE, 2017-2021, in USD Million
5.2.3.2 Situation & Development
5.2.4 Market in Starch Blends
5.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Starch Blends, 2017-2021, in USD Million
5.2.4.2 Situation & Development
5.2.5 Market in PLA
5.2.5.1 Market Size
Figure Global Market Amount and Growth Rate in PLA, 2017-2021, in USD Million
5.2.5.2 Situation & Development
5.2.6 Market in Others
5.2.6.1 Market Size
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million
5.2.6.2 Situation & Development
6 END-USE SEGMENT
6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD
6.2 Segment Subdivision
6.2.1 Market in Packing Industry
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Packing Industry, 2017-2021, in USD Million
6.2.1.2 Situation & Development
6.2.2 Market in Automotive Industry
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Automotive Industry, 2017-2021, in USD Million
6.2.2.2 Situation & Development
6.2.3 Market in Bottles manufacturing
6.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Bottles manufacturing, 2017-2021, in USD Million
6.2.3.2 Situation & Development
6.2.4 Market in Others
6.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million
6.2.4.2 Situation & Development
7 MARKET FORECAST & TREND
7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2022-2027, in Million USD
7.2 Consumption Forecast
7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2022-2027, in Million USD
7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2022-2027, in Million USD
7.3 Investment Trend
7.4 Consumption Trend
8 PRICE & CHANNEL
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio
8.2 Channel Segment
9 MARKET DRIVERS & INVESTMENT ENVIRONMENT
9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Biologics and Biosimilars Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 RESEARCH CONCLUSION
LIST OF TABLES
Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027
Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027
Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027
Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD
Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Production Amount List in 2021
Table NatureWorks Overview List
Table Biologics and Biosimilars Business Operation of NatureWorks (Production Amount (Million USD), Cost, Gross Margin)
Table Braskem Overview List
Table Biologics and Biosimilars Business Operation of Braskem (Production Amount (Million USD), Cost, Gross Margin)
Table BASF Overview List
Table Biologics and Biosimilars Business Operation of BASF (Production Amount (Million USD), Cost, Gross Margin)
Table Arkema Overview List
Table Biologics and Biosimilars Business Operation of Arkema (Production Amount (Million USD), Cost, Gross Margin)
Table DuPont Overview List
Table Biologics and Biosimilars Business Operation of DuPont (Production Amount (Million USD), Cost, Gross Margin)
Table Novamont Overview List
Table Biologics and Biosimilars Business Operation of Novamont (Production Amount (Million USD), Cost, Gross Margin)
Table Corbion Overview List
Table Biologics and Biosimilars Business Operation of Corbion (Production Amount (Million USD), Cost, Gross Margin)
Table Metabolix Overview List
Table Biologics and Biosimilars Business Operation of Metabolix (Production Amount (Million USD), Cost, Gross Margin)
Table PSM Overview List
Table Biologics and Biosimilars Business Operation of PSM (Production Amount (Million USD), Cost, Gross Margin)
Table PolyOne Overview List
Table Biologics and Biosimilars Business Operation of PolyOne (Production Amount (Million USD), Cost, Gross Margin)
Table Biome Bioplastics Overview List
Table Biologics and Biosimilars Business Operation of Biome Bioplastics (Production Amount (Million USD), Cost, Gross Margin)
Table Biomer Overview List
Table Biologics and Biosimilars Business Operation of Biomer (Production Amount (Million USD), Cost, Gross Margin)
Table FKuR Overview List
Table Biologics and Biosimilars Business Operation of FKuR (Production Amount (Million USD), Cost, Gross Margin)
Table Trellis Bioplastics Overview List
Table Biologics and Biosimilars Business Operation of Trellis Bioplastics (Production Amount (Million USD), Cost, Gross Margin)
Table Kingfa Overview List
Table Biologics and Biosimilars Business Operation of Kingfa (Production Amount (Million USD), Cost, Gross Margin)
Table Cardia Bioplastics Overview List
Table Biologics and Biosimilars Business Operation of Cardia Bioplastics (Production Amount (Million USD), Cost, Gross Margin)
Table Grabio Overview List
Table Biologics and Biosimilars Business Operation of Grabio (Production Amount (Million USD), Cost, Gross Margin)
Table MHG Overview List
Table Biologics and Biosimilars Business Operation of MHG (Production Amount (Million USD), Cost, Gross Margin)
Table Myriant Overview List
Table Biologics and Biosimilars Business Operation of Myriant (Production Amount (Million USD), Cost, Gross Margin)
Table Mitsubishi Overview List
Table Biologics and Biosimilars Business Operation of Mitsubishi (Production Amount (Million USD), Cost, Gross Margin)
Table Zhejiang Hisun Biomaterials Overview List
Table Biologics and Biosimilars Business Operation of Zhejiang Hisun Biomaterials (Production Amount (Million USD), Cost, Gross Margin)
Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD
Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD
Table Global Market Forecast by Region Segment 2022-2027, in Million USD
Table Global Market Amount by Product Type Segment 2022-2027, in Million USD
Table Global Market Amount by End-Use Segment 2022-2027, in Million USD
Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027
Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027
Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027
Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD
Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Production Amount List in 2021
Table NatureWorks Overview List
Table Biologics and Biosimilars Business Operation of NatureWorks (Production Amount (Million USD), Cost, Gross Margin)
Table Braskem Overview List
Table Biologics and Biosimilars Business Operation of Braskem (Production Amount (Million USD), Cost, Gross Margin)
Table BASF Overview List
Table Biologics and Biosimilars Business Operation of BASF (Production Amount (Million USD), Cost, Gross Margin)
Table Arkema Overview List
Table Biologics and Biosimilars Business Operation of Arkema (Production Amount (Million USD), Cost, Gross Margin)
Table DuPont Overview List
Table Biologics and Biosimilars Business Operation of DuPont (Production Amount (Million USD), Cost, Gross Margin)
Table Novamont Overview List
Table Biologics and Biosimilars Business Operation of Novamont (Production Amount (Million USD), Cost, Gross Margin)
Table Corbion Overview List
Table Biologics and Biosimilars Business Operation of Corbion (Production Amount (Million USD), Cost, Gross Margin)
Table Metabolix Overview List
Table Biologics and Biosimilars Business Operation of Metabolix (Production Amount (Million USD), Cost, Gross Margin)
Table PSM Overview List
Table Biologics and Biosimilars Business Operation of PSM (Production Amount (Million USD), Cost, Gross Margin)
Table PolyOne Overview List
Table Biologics and Biosimilars Business Operation of PolyOne (Production Amount (Million USD), Cost, Gross Margin)
Table Biome Bioplastics Overview List
Table Biologics and Biosimilars Business Operation of Biome Bioplastics (Production Amount (Million USD), Cost, Gross Margin)
Table Biomer Overview List
Table Biologics and Biosimilars Business Operation of Biomer (Production Amount (Million USD), Cost, Gross Margin)
Table FKuR Overview List
Table Biologics and Biosimilars Business Operation of FKuR (Production Amount (Million USD), Cost, Gross Margin)
Table Trellis Bioplastics Overview List
Table Biologics and Biosimilars Business Operation of Trellis Bioplastics (Production Amount (Million USD), Cost, Gross Margin)
Table Kingfa Overview List
Table Biologics and Biosimilars Business Operation of Kingfa (Production Amount (Million USD), Cost, Gross Margin)
Table Cardia Bioplastics Overview List
Table Biologics and Biosimilars Business Operation of Cardia Bioplastics (Production Amount (Million USD), Cost, Gross Margin)
Table Grabio Overview List
Table Biologics and Biosimilars Business Operation of Grabio (Production Amount (Million USD), Cost, Gross Margin)
Table MHG Overview List
Table Biologics and Biosimilars Business Operation of MHG (Production Amount (Million USD), Cost, Gross Margin)
Table Myriant Overview List
Table Biologics and Biosimilars Business Operation of Myriant (Production Amount (Million USD), Cost, Gross Margin)
Table Mitsubishi Overview List
Table Biologics and Biosimilars Business Operation of Mitsubishi (Production Amount (Million USD), Cost, Gross Margin)
Table Zhejiang Hisun Biomaterials Overview List
Table Biologics and Biosimilars Business Operation of Zhejiang Hisun Biomaterials (Production Amount (Million USD), Cost, Gross Margin)
Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD
Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD
Table Global Market Forecast by Region Segment 2022-2027, in Million USD
Table Global Market Amount by Product Type Segment 2022-2027, in Million USD
Table Global Market Amount by End-Use Segment 2022-2027, in Million USD
LIST OF FIGURES
Figure Biologics and Biosimilars Picture List
Figure Global Market Size and Forecast with Growth Rate, 2017-2027
Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD
Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD
Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD
Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD
Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD
Figure Global Market Size and Growth Rate, 2017-2021, in Million USD
Figure Global Competition Sketch Overview
Figure Global Production Amount Share by Manufacturers in 2021, in Million USD
Figure Global Market Amount and Growth Rate in Bio-PET, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in PHA, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Bio-PE, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Starch Blends, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in PLA, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Packing Industry, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Automotive Industry, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Bottles manufacturing, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million
Figure Cost Component Ratio
Figure Biologics and Biosimilars Picture List
Figure Global Market Size and Forecast with Growth Rate, 2017-2027
Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD
Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD
Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD
Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD
Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD
Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD
Figure Global Market Size and Growth Rate, 2017-2021, in Million USD
Figure Global Competition Sketch Overview
Figure Global Production Amount Share by Manufacturers in 2021, in Million USD
Figure Global Market Amount and Growth Rate in Bio-PET, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in PHA, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Bio-PE, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Starch Blends, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in PLA, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Packing Industry, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Automotive Industry, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Bottles manufacturing, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million
Figure Cost Component Ratio
